Company Filing History:
Years Active: 2014-2023
Title: Neil Martin O'Brien Simpson: Innovator in Antibody Research
Introduction
Neil Martin O'Brien Simpson is a prominent inventor based in Melbourne, Australia. He has made significant contributions to the field of antibody research, holding a total of four patents. His work focuses on the prevention, treatment, and diagnosis of various infections through innovative antibody technologies.
Latest Patents
Among his latest patents, one notable invention is related to antibodies for the prevention, treatment, and diagnosis of infections. This patent discloses antibodies raised against a chimeric or fusion protein, which includes a first peptide linked to a second peptide or polypeptide. The first peptide comprises a region of a trypsin-like enzyme, while the second peptide or polypeptide contains an adhesin domain. Another significant patent involves methods of preparing antibodies, which outlines techniques for generating cellular and humoral responses to prevent and treat related conditions and diseases. This method includes immunizing a non-human animal with a chimeric or fusion protein similar to the one described in his first patent.
Career Highlights
Neil Martin O'Brien Simpson is currently associated with Oral Health Australia Pty Ltd, where he continues to advance his research in antibody development. His innovative work has positioned him as a key figure in the field, contributing to advancements in medical treatments and diagnostics.
Collaborations
He has collaborated with notable colleagues, including Eric Charles Reynolds and Keith J Cross, who share his commitment to advancing health through innovative research.
Conclusion
Neil Martin O'Brien Simpson's contributions to antibody research exemplify the impact of innovation in healthcare. His patents and ongoing work continue to pave the way for new treatments and diagnostic methods, showcasing the importance of research in improving public health.